| Brand Name | Betaderm |
| Generic Name | Betamethasone Valerate |
| INN Name | Betamethasone |
| Drug Class | Corticosteroid |
| Drug Subclass | Topical corticosteroid - potent |
| Formulation | Cream, Ointment, Lotion |
| Strength | 0.1%, 0.05% |
| Package Size | 15g, 30g, 60g |
| Route of Administration | Topical |
| Prescription Status | Rx |
| DIN Number | 02242492 (example for 0.1% cream in Canada, verify with Health Canada) |
| NDC Code | Not applicable (primarily Canadian product) |
| ATC Code | D07AC01 |
| Manufacturer | Taro Pharmaceuticals Inc. (Canada), various generics |
| Active Ingredients | Betamethasone Valerate 0.1% or 0.05% |
| Inactive Ingredients | Cetyl alcohol,Stearyl alcohol,White petrolatum,Mineral oil,Purified water,Sodium phosphate monobasic,Phosphoric acid (for pH adjustment) |
| Mechanism of Action | Betamethasone valerate is a synthetic glucocorticoid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It binds to glucocorticoid receptors, modulating gene expression to inhibit the production of inflammatory mediators such as prostaglandins and leukotrienes, reducing inflammation and immune response in the skin. |
| Pharmacokinetics | [object Object] |
| Pharmacodynamics | Exerts anti-inflammatory effects by suppressing immune responses and reducing capillary permeability, leading to decreased edema and pruritus in dermatologic conditions. May cause skin atrophy or HPA axis suppression with prolonged use or excessive application. |
| Indications | Eczema (atopic dermatitis),Psoriasis (excluding widespread plaque psoriasis),Contact dermatitis,Allergic dermatitis,Other corticosteroid-responsive dermatoses |
| Contraindications | Hypersensitivity to betamethasone or any component of the formulation,Untreated bacterial, fungal, or viral skin infections (e.g., herpes simplex, tuberculosis of the skin),Rosacea,Acne vulgaris,Perioral dermatitis,Use on face, groin, or axillae for prolonged periods unless directed by a physician |
| Warnings | Risk of hypothalamic-pituitary-adrenal (HPA) axis suppression with prolonged use, large areas, or occlusion, especially in children.,Avoid abrupt discontinuation after long-term use to prevent rebound effects.,Not for ophthalmic use; avoid contact with eyes.,May cause local skin atrophy, striae, or telangiectasia with chronic use.,Use caution in pediatric patients due to higher risk of systemic absorption. |
| Side Effects | [object Object] |
| Adult Dosage | Apply a thin layer to the affected area 1-2 times daily, not to exceed 2 weeks of continuous use without medical supervision. Maximum weekly dose should not exceed 45g of 0.1% or 50g of 0.05% formulation. |
| Pediatric Dosage | Use with caution in children; apply thinly 1-2 times daily for shortest duration possible (typically under 7 days). Not recommended for children under 1 year. Consult physician for use in pediatric patients. |
| Geriatric Dosage | Use lowest effective dose and shortest duration due to thinner skin and increased risk of atrophy or systemic absorption. Monitor for adverse effects. |
| Typical Duration | 7-14 days for acute conditions; reassess if no improvement. Chronic conditions may require intermittent use under medical supervision. |
| Storage | Store at room temperature (15-25°C), away from heat and direct sunlight. Do not freeze. Keep out of reach of children. |
| Pregnancy Category | C (use only if benefit justifies potential risk to fetus; minimal systemic absorption expected with proper use) |
| Breastfeeding Notes | Considered compatible with breastfeeding if used on small areas and not on the breast. Avoid application to areas where infant may have direct contact. Minimal systemic absorption expected with proper use. |
| Drug-Drug Interactions | Minimal systemic interactions due to low absorption; however, caution with other topical corticosteroids to avoid additive effects.,Occlusive dressings may increase systemic absorption, potentially interacting with systemic drugs metabolized by CYP3A4 if significant absorption occurs. |
| Herb-Drug Interactions | Limited data on topical corticosteroids; however, herbs with anti-inflammatory effects (e.g., licorice root, turmeric) applied topically may have additive effects.,Avoid concurrent use of irritating herbal topicals (e.g., capsaicin) as they may exacerbate skin irritation. |
| Herbal Alternatives | Calendula officinalis (marigold) cream for mild skin inflammation or irritation.,Aloe vera gel for soothing minor skin irritations or burns.,Chamomile (Matricaria chamomilla) topical preparations for anti-inflammatory effects on mild dermatitis.,Note: Herbal alternatives may not be as effective for moderate to severe dermatoses and lack rigorous clinical evidence compared to betamethasone. |
| Naturopathic Notes | Betaderm is effective for acute inflammatory skin conditions but should be used as a short-term solution due to risks of skin atrophy and HPA axis suppression with prolonged use. Naturopathic approaches prioritize identifying and addressing underlying causes of skin conditions (e.g., diet, stress, allergens) alongside symptomatic relief. Consider integrating topical herbal remedies like calendula or chamomile for mild cases or as adjuncts to reduce corticosteroid dependency. Encourage barrier repair with emollients and lifestyle modifications. Always taper usage under guidance to prevent rebound flares. Consult with a healthcare provider before combining with herbal treatments to avoid potential irritation or interactions. |
| Reference | AI-generated, reviewed by Shanta |
| URL |
© 2026 none. All rights reserved.